Total Payments
$9,958
2024 Payments
$2,028
Companies
55
Transactions
451
Medicare Patients
9,689
Medicare Billing
$834,607
Payment Breakdown by Category
Food & Beverage$9,527 (95.7%)
Education$410.36 (4.1%)
Other$20.61 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,527 | 439 | 95.7% |
| Education | $410.36 | 11 | 4.1% |
| Entertainment | $20.61 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,437 | 71 | $0 (2024) |
| Axonics, Inc. | $814.60 | 17 | $0 (2024) |
| ABBVIE INC. | $640.25 | 34 | $0 (2024) |
| PFIZER INC. | $619.54 | 43 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $566.66 | 18 | $0 (2024) |
| Janssen Biotech, Inc. | $485.18 | 23 | $0 (2024) |
| Teleflex LLC | $480.38 | 18 | $0 (2024) |
| NeoTract Inc. | $468.69 | 11 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $445.35 | 19 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $348.84 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,028 | 75 | Axonics, Inc. ($287.94) |
| 2023 | $1,579 | 66 | Axonics, Inc. ($308.07) |
| 2022 | $1,338 | 52 | Astellas Pharma US Inc ($209.69) |
| 2021 | $1,417 | 71 | Astellas Pharma US Inc ($212.89) |
| 2020 | $663.47 | 33 | Astellas Pharma US Inc ($117.03) |
| 2019 | $1,007 | 53 | Astellas Pharma US Inc ($308.66) |
| 2018 | $1,080 | 54 | NeoTract Inc. ($321.31) |
| 2017 | $844.39 | 47 | AbbVie, Inc. ($216.75) |
All Payment Transactions
451 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/05/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $127.55 | General |
| Category: Urology | ||||||
| 12/03/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $113.37 | General |
| Category: Urology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: HORMONE THERAPY | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: Oncology | ||||||
| 11/13/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/31/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $146.59 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $19.08 | General |
| Category: ONCOLOGY | ||||||
| 10/06/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $20.66 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $68.00 | General |
| 09/30/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Oncology | ||||||
| 09/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/24/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/18/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: ONCOLOGY | ||||||
| 09/16/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/05/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $20.67 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,697 | 3,623 | $790,191 | $224,824 |
| 2022 | 32 | 2,692 | 4,551 | $775,972 | $230,071 |
| 2021 | 31 | 2,638 | 6,196 | $805,231 | $245,016 |
| 2020 | 22 | 1,662 | 2,241 | $383,093 | $134,697 |
Total Patients
9,689
Total Services
16,611
Medicare Billing
$834,607
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 601 | 917 | $270,780 | $87,370 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 162 | 162 | $57,996 | $20,263 | 34.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 125 | 235 | $27,495 | $15,336 | 55.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 205 | $43,445 | $14,291 | 32.9% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 41 | 41 | $27,906 | $12,403 | 44.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 143 | 171 | $102,600 | $11,231 | 10.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 40 | 167 | $14,195 | $8,499 | 59.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 52 | 53 | $16,748 | $7,713 | 46.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 52 | $24,555 | $7,222 | 29.4% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 41 | 41 | $15,006 | $6,852 | 45.7% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 48 | 48 | $21,840 | $4,908 | 22.5% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 51 | 51 | $11,985 | $4,305 | 35.9% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 23 | 23 | $16,123 | $4,010 | 24.9% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 23 | 74 | $36,852 | $3,118 | 8.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 642 | 870 | $6,960 | $2,687 | 38.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $4,945 | $2,515 | 50.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 19 | 19 | $9,633 | $2,274 | 23.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 16 | 17 | $17,500 | $1,608 | 9.2% |
| 52204 | Biopsy of bladder using an endoscope | Facility | 2023 | 12 | 14 | $14,431 | $1,527 | 10.6% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 11 | 18 | $3,990 | $1,357 | 34.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 47 | 47 | $11,750 | $1,206 | 10.3% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 40 | 40 | $17,480 | $1,096 | 6.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,180 | $769.92 | 65.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 77 | 85 | $1,010 | $714.00 | 70.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 71 | 77 | $5,180 | $662.43 | 12.8% |
About Dr. Joseph Graversen, M.D
Dr. Joseph Graversen, M.D is a Urology healthcare provider based in Paoli, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396935912.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Graversen, M.D has received a total of $9,958 in payments from pharmaceutical and medical device companies, with $2,028 received in 2024. These payments were reported across 451 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($9,527).
As a Medicare-enrolled provider, Graversen has provided services to 9,689 Medicare beneficiaries, totaling 16,611 services with total Medicare billing of $834,607. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology, Urology
- Location Paoli, PA
- Active Since 07/30/2007
- Last Updated 08/14/2013
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1396935912
Products in Payments
- XTANDI (Drug) $943.86
- Axonics (Device) $684.65
- PROVENGE (Drug) $600.48
- BOTOX (Biological) $538.16
- UroLift (Device) $474.97
- ERLEADA (Drug) $311.33
- ELIGARD (Drug) $306.67
- MYRBETRIQ (Drug) $295.56
- GEMTESA (Drug) $289.34
- KEYTRUDA (Biological) $287.43
- Nubeqa (Drug) $284.15
- UroLift System (Device) $268.42
- Noctiva (Drug) $258.55
- Myrbetriq (Drug) $252.37
- Androgel (Drug) $250.43
- INTERSTIM (Device) $220.22
- UROLIFT (Device) $188.09
- PROLARIS (Device) $175.73
- XIAFLEX (Biological) $175.37
- Natesto (Drug) $174.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.